THE International Biotechnology trust has revealed it is considering increasing its size through a C Share issue as part of the company's investment strategy.
It follows the company’s announcement that the net asset value of the trust’s ordinary shares has risen from £122.37p on November 15 2005 to £155.97p at the close of November 14 2006, a rise of 27.5pc....
Moves to overweight equities and fixed income
The Big Interview: Focus on ethical investment
View from the front row
'No control or oversight'
359 new customers in 2018